MDxHealth Statistics
Total Valuation
MDxHealth has a market cap or net worth of $78.04 million. The enterprise value is $171.25 million.
| Market Cap | 78.04M |
| Enterprise Value | 171.25M |
Important Dates
The last earnings date was Wednesday, May 1, 2024, before market open.
| Earnings Date | May 1, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MDxHealth has 27.29 million shares outstanding.
| Shares Outstanding | 27.29M |
| Owned by Insiders (%) | 2.63% |
| Owned by Institutions (%) | 39.37% |
| Float | 16.98M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.04 |
| Forward PS | 0.91 |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.27 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.69
| Current Ratio | 1.69 |
| Quick Ratio | 1.43 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.51 |
Financial Efficiency
Return on equity (ROE) is -314.60% and return on invested capital (ROIC) is -23.62%.
| Return on Equity (ROE) | -314.60% |
| Return on Assets (ROA) | -30.20% |
| Return on Capital (ROIC) | -23.62% |
| Revenue Per Employee | $298,917 |
| Profits Per Employee | -$158,341 |
| Employee Count | 252 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 11.06 |
Taxes
In the past 12 months, MDxHealth has paid $1,000 in taxes.
| Income Tax | 1,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.90% in the last 52 weeks. The beta is -370,445.47, so MDxHealth's price volatility has been lower than the market average.
| Beta (1Y) | -370,445.47 |
| 52-Week Price Change | -26.90% |
| 50-Day Moving Average | 2.65 |
| 200-Day Moving Average | 3.13 |
| Relative Strength Index (RSI) | 55.30 |
| Average Volume (30 Days) | 70,983 |
Short Selling Information
| Short Interest | 73,926 |
| Short Previous Month | 64,975 |
| Short % of Shares Out | 0.41% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 1.04 |
Income Statement
In the last 12 months, MDxHealth had revenue of $75.33 million and -$39.90 million in losses. Loss per share was -$13.70.
| Revenue | 75.33M |
| Gross Profit | 47.28M |
| Operating Income | -25.21M |
| Pretax Income | -39.90M |
| Net Income | -39.90M |
| EBITDA | -21.40M |
| EBIT | -28.52M |
| Loss Per Share | -$13.70 |
Balance Sheet
The company has $14.49 million in cash and $107.70 million in debt, giving a net cash position of -$93.21 million or -$3.42 per share.
| Cash & Cash Equivalents | 14.49M |
| Total Debt | 107.70M |
| Net Cash | -93.21M |
| Net Cash Per Share | -$3.42 |
| Equity / Book Value | -973,000 |
| Book Value Per Share | -0.04 |
| Working Capital | 13.04M |
Cash Flow
In the last 12 months, operating cash flow was -$22.74 million and capital expenditures -$2.18 million, giving a free cash flow of -$24.92 million.
| Operating Cash Flow | -22.74M |
| Capital Expenditures | -2.18M |
| Free Cash Flow | -24.92M |
| FCF Per Share | -$9.13 |
Margins
Gross margin is 62.76%, with operating and profit margins of -33.47% and -52.97%.
| Gross Margin | 62.76% |
| Operating Margin | -33.47% |
| Pretax Margin | -52.97% |
| Profit Margin | -52.97% |
| EBITDA Margin | -28.40% |
| EBIT Margin | -37.86% |
| FCF Margin | -33.09% |
Dividends & Yields
MDxHealth does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -67.53% |
| Shareholder Yield | -67.53% |
| Earnings Yield | -51.13% |
| FCF Yield | -31.94% |
Analyst Forecast
The average price target for MDxHealth is $7.33, which is 154.51% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.33 |
| Price Target Difference | 154.51% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 17.34% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 14, 2023. It was a reverse split with a ratio of 1:10.
| Last Split Date | Nov 14, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
MDxHealth has an Altman Z-Score of -3.55 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.55 |
| Piotroski F-Score | 3 |